ATE526332T1 - Verfahren zur herstellung von pentacyclischem taxan - Google Patents
Verfahren zur herstellung von pentacyclischem taxanInfo
- Publication number
- ATE526332T1 ATE526332T1 AT05737233T AT05737233T ATE526332T1 AT E526332 T1 ATE526332 T1 AT E526332T1 AT 05737233 T AT05737233 T AT 05737233T AT 05737233 T AT05737233 T AT 05737233T AT E526332 T1 ATE526332 T1 AT E526332T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- oral
- compound
- formula
- antitumor compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Epoxy Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004136359 | 2004-04-30 | ||
| PCT/JP2005/008034 WO2005105807A1 (ja) | 2004-04-30 | 2005-04-27 | 五環性タキサンの製造方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE526332T1 true ATE526332T1 (de) | 2011-10-15 |
Family
ID=35241616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05737233T ATE526332T1 (de) | 2004-04-30 | 2005-04-27 | Verfahren zur herstellung von pentacyclischem taxan |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US7456302B2 (de) |
| EP (1) | EP1741716B8 (de) |
| JP (1) | JP4800205B2 (de) |
| KR (1) | KR101186475B1 (de) |
| CN (1) | CN1942473B (de) |
| AT (1) | ATE526332T1 (de) |
| CA (1) | CA2565013C (de) |
| DK (1) | DK1741716T3 (de) |
| ES (1) | ES2371947T3 (de) |
| HK (1) | HK1094582A1 (de) |
| IL (1) | IL178918A (de) |
| MX (1) | MXPA06012588A (de) |
| PT (1) | PT1741716E (de) |
| WO (1) | WO2005105807A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI2084174T1 (sl) * | 2006-10-10 | 2013-10-30 | Gilead Pharmasset Llc | Priprava nukleozidov ribofuranozil pririmidinov |
| WO2008121476A1 (en) * | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| US8697892B2 (en) | 2010-06-30 | 2014-04-15 | Gfv, Llc | Taxane compounds, compositions and methods |
| US8785669B2 (en) * | 2010-06-30 | 2014-07-22 | Gfv, Llc | Taxane compounds, compositions and methods |
| FR2986526A1 (fr) | 2012-02-03 | 2013-08-09 | Sanofi Sa | Procede de preparation de derives du taxol et certains composes intermediaires |
| SG11201406885VA (en) * | 2012-04-25 | 2014-11-27 | Gfv Llc | Taxane compounds, compositions and methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3746563B2 (ja) * | 1995-04-28 | 2006-02-15 | 第一製薬株式会社 | 五環性化合物 |
| US6075140A (en) * | 1995-04-28 | 2000-06-13 | Daiichi Pharmaceutical Co., Ltd. | Pentacyclic compound |
| US6008417A (en) * | 1997-10-20 | 1999-12-28 | Roche Vitamins Inc. | Process for making metabolites of lycopene |
| JP3776799B2 (ja) * | 1999-10-15 | 2006-05-17 | 第一製薬株式会社 | 五環性タキサン化合物 |
| US6677456B2 (en) * | 1999-10-15 | 2004-01-13 | Daiichi Pharmaceutical Co., Ltd. | Pentacyclic taxan compound |
| JP3776818B2 (ja) * | 2001-03-07 | 2006-05-17 | 第一製薬株式会社 | 五環性タキサン化合物およびその製造方法 |
| CA2468953C (en) | 2001-11-29 | 2010-05-11 | Daiichi Pharmaceutical Co., Ltd. | Taxane derivative crystal and method for preparing the same |
-
2005
- 2005-04-27 ES ES05737233T patent/ES2371947T3/es active Active
- 2005-04-27 KR KR1020067025289A patent/KR101186475B1/ko not_active IP Right Cessation
- 2005-04-27 US US11/579,140 patent/US7456302B2/en active Active
- 2005-04-27 CN CN2005800117870A patent/CN1942473B/zh not_active Expired - Fee Related
- 2005-04-27 PT PT05737233T patent/PT1741716E/pt unknown
- 2005-04-27 MX MXPA06012588A patent/MXPA06012588A/es active IP Right Grant
- 2005-04-27 DK DK05737233.6T patent/DK1741716T3/da active
- 2005-04-27 WO PCT/JP2005/008034 patent/WO2005105807A1/ja active Application Filing
- 2005-04-27 CA CA2565013A patent/CA2565013C/en not_active Expired - Fee Related
- 2005-04-27 JP JP2006512820A patent/JP4800205B2/ja not_active Expired - Fee Related
- 2005-04-27 EP EP05737233A patent/EP1741716B8/de not_active Not-in-force
- 2005-04-27 AT AT05737233T patent/ATE526332T1/de active
-
2006
- 2006-10-29 IL IL178918A patent/IL178918A/en not_active IP Right Cessation
-
2007
- 2007-02-15 HK HK07101873.3A patent/HK1094582A1/xx not_active IP Right Cessation
-
2008
- 2008-09-25 US US12/238,070 patent/US7678919B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1094582A1 (en) | 2007-04-04 |
| IL178918A0 (en) | 2007-03-08 |
| PT1741716E (pt) | 2011-12-21 |
| US20090030209A1 (en) | 2009-01-29 |
| EP1741716A4 (de) | 2009-03-04 |
| DK1741716T3 (da) | 2011-11-28 |
| US7456302B2 (en) | 2008-11-25 |
| CA2565013C (en) | 2013-01-08 |
| JPWO2005105807A1 (ja) | 2008-03-13 |
| MXPA06012588A (es) | 2007-01-31 |
| KR101186475B1 (ko) | 2012-09-27 |
| JP4800205B2 (ja) | 2011-10-26 |
| EP1741716B8 (de) | 2012-02-22 |
| CN1942473B (zh) | 2011-02-02 |
| EP1741716A1 (de) | 2007-01-10 |
| CN1942473A (zh) | 2007-04-04 |
| US7678919B2 (en) | 2010-03-16 |
| KR20070026553A (ko) | 2007-03-08 |
| ES2371947T3 (es) | 2012-01-11 |
| EP1741716B1 (de) | 2011-09-28 |
| WO2005105807A1 (ja) | 2005-11-10 |
| CA2565013A1 (en) | 2005-11-10 |
| IL178918A (en) | 2011-06-30 |
| US20070167630A1 (en) | 2007-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE534629T1 (de) | Verfahren und verbindungen zur herstellung von cc-1065-analoga | |
| ATE556085T1 (de) | Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna | |
| ATE526332T1 (de) | Verfahren zur herstellung von pentacyclischem taxan | |
| ATE444747T1 (de) | Verfahren zur herstellung von expoxybutanol- zwischenprodukten | |
| ATE506352T1 (de) | Verfahren zur herstellung von optional 2- substituierten 1,6-dihydro-6-oxo-4- pyrimidincarboxylsäuren | |
| ATE451360T1 (de) | Halbsynthetisches verfahren zur herstellung von 10-desacetyl-n-desbenzoyl-paclitaxel | |
| ATE536875T1 (de) | Verfahren und zwischenzusammensetzungen zur herstellung von statinen, insbesondere rosuvastatin | |
| RS51144B (sr) | Postupak za izradu inhibitora triptaze | |
| ATE378312T1 (de) | Verfahren zur herstellung von adapalene | |
| TW200619201A (en) | Process for the preparation of pyrazoles | |
| ATE525364T1 (de) | Verfahren zur herstellung von 3,6-dihydro-1,3,5- triazin-derivaten | |
| DE602005010369D1 (de) | 2-thiaquinolizidines als Glycosidase- und Glycosyltransferase-Inhibitoren | |
| ATE437883T1 (de) | Verfahren zur trennung von zirkonium und hafnium | |
| ATE527228T1 (de) | Verfahren zur herstellung von beta-santalol und derivaten davon | |
| ATE208381T1 (de) | Verfahren zur herstellung von taxol und seiner derivate | |
| ATE423775T1 (de) | Verfahren zur herstellung von lactonen | |
| ATE469141T1 (de) | Verfahren zur herstellung von substituierten thiophensulfonylisocyanaten | |
| ATE486851T1 (de) | Verfahren zur herstellung von montekulast | |
| ATE446960T1 (de) | Verfahren zur herstellung von ziprasidone | |
| ATE405554T1 (de) | Verfahren zur herstellung von pramipexole | |
| ATE499353T1 (de) | Verfahren zur herstellung von taxanderivaten | |
| ATE515502T1 (de) | Verfahren zur herstellung von tetranorlabdanderivaten | |
| ATE374758T1 (de) | Chirale heptinderivate zur herstellung von epothilonen und verfahren zu deren herstellung | |
| ATE505456T1 (de) | Verfahren zur herstellung eines 2-substituierten pyridinderivats | |
| ATE477233T1 (de) | Verfahren zur herstellung von beta-hydroxyester |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1741716 Country of ref document: EP |